Literature DB >> 26634690

Recent advances in the pathogenesis and treatment of osteoporosis.

Elizabeth M Curtis1, Rebecca J Moon2, Elaine M Dennison1, Nicholas C Harvey3, Cyrus Cooper4.   

Abstract

Over recent decades, the perception of osteoporosis has changed from that of an inevitable consequence of ageing, to that of a well characterised and treatable chronic non-communicable disease, with major impacts on individuals, healthcare systems and societies. Characterisation of its pathophysiology from the hierarchical structure of bone and the role of its cell population, development of effective strategies for the identification of those most appropriate for treatment, and an increasing armamentarium of efficacious pharmacological therapies, have underpinned this evolution. Despite this marked progress, individuals who experience a fragility fracture remain under-treated in many areas of the world, and there is substantial need for investment both in secondary and primary prevention globally. In this brief article, we give an overview of the pathogenesis of osteoporosis, and summarise current and future approaches to its assessment and treatment. © Royal College of Physicians 2015. All rights reserved.

Entities:  

Keywords:  dxa; epidemiology; osteoporosis; pathophysiology; risk assessment; ­treatment

Mesh:

Year:  2015        PMID: 26634690      PMCID: PMC4876921          DOI: 10.7861/clinmedicine.15-6-s92

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  26 in total

Review 1.  Bone mineral crystal size.

Authors: 
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

2.  Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Authors:  J Y Reginster; E Seeman; M C De Vernejoul; S Adami; J Compston; C Phenekos; J P Devogelaer; M Diaz Curiel; A Sawicki; S Goemaere; O H Sorensen; D Felsenberg; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

3.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.

Authors:  A M Grant; A Avenell; M K Campbell; A M McDonald; G S MacLennan; G C McPherson; F H Anderson; C Cooper; R M Francis; C Donaldson; W J Gillespie; C M Robinson; D J Torgerson; W A Wallace
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

4.  Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study.

Authors:  M C Chapuy; R Pamphile; E Paris; C Kempf; M Schlichting; S Arnaud; P Garnero; P J Meunier
Journal:  Osteoporos Int       Date:  2002-03       Impact factor: 4.507

5.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

6.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

7.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

8.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis.

Authors:  C J Hernandez; G S Beaupré; D R Carter
Journal:  Osteoporos Int       Date:  2003-08-07       Impact factor: 4.507

Review 10.  The position of strontium ranelate in today's management of osteoporosis.

Authors:  J-Y Reginster; M-L Brandi; J Cannata-Andía; C Cooper; B Cortet; J-M Feron; H Genant; S Palacios; J D Ringe; R Rizzoli
Journal:  Osteoporos Int       Date:  2015-04-14       Impact factor: 4.507

View more
  11 in total

Review 1.  Novel advances in the treatment of osteoporosis.

Authors:  Christopher K Y Chan; Alice Mason; Cyrus Cooper; Elaine Dennison
Journal:  Br Med Bull       Date:  2016-08-24       Impact factor: 4.291

2.  Rheumatoid arthritis and bone health.

Authors:  Shanze Ashai; Nicholas C Harvey
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

Review 3.  The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).

Authors:  N C Harvey; E Biver; J-M Kaufman; J Bauer; J Branco; M L Brandi; O Bruyère; V Coxam; A Cruz-Jentoft; E Czerwinski; H Dimai; P Fardellone; F Landi; J-Y Reginster; B Dawson-Hughes; J A Kanis; R Rizzoli; C Cooper
Journal:  Osteoporos Int       Date:  2016-10-20       Impact factor: 4.507

4.  lncRNA WT1-AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53.

Authors:  Chaoqun Wang; Quan Xie; Wen Sun; Ying Zhou; Yu Liu
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

5.  Relation between phalangeal bone mineral density and radiographic knee osteoarthritis: a cross-sectional study.

Authors:  Zhen-Han Deng; Chao Zeng; Yu-Sheng Li; Tuo Yang; Hui Li; Jie Wei; Guang-Hua Lei
Journal:  BMC Musculoskelet Disord       Date:  2016-02-11       Impact factor: 2.362

6.  Dose-dependent Effects of Strontium Ranelate on Ovariectomy Rat Bone Marrow Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells.

Authors:  Xiaojing Guo; Silong Wei; Mengmeng Lu; Zhengwei Shao; Jiayu Lu; Lunguo Xia; Kaili Lin; Derong Zou
Journal:  Int J Biol Sci       Date:  2016-11-25       Impact factor: 6.580

7.  LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts.

Authors:  Ye Han; Chunying Liu; Ming Lei; Shaosong Sun; Wenkui Zheng; Yanan Niu; Xi Xia
Journal:  J Orthop Surg Res       Date:  2019-12-09       Impact factor: 2.359

Review 8.  Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Authors:  S Rozenberg; N Al-Daghri; M Aubertin-Leheudre; M-L Brandi; A Cano; P Collins; C Cooper; A R Genazzani; T Hillard; J A Kanis; J-M Kaufman; I Lambrinoudaki; A Laslop; E McCloskey; S Palacios; D Prieto-Alhambra; J-Y Reginster; R Rizzoli; G Rosano; F Trémollieres; N C Harvey
Journal:  Osteoporos Int       Date:  2020-07-08       Impact factor: 4.507

9.  Promoting osteointegration effect of Cu-alloyed titanium in ovariectomized rats.

Authors:  Xiyue Zhang; Hui Liu; Ling Li; Cuishan Huang; Xiangbo Meng; Junzuo Liu; Xueling Bai; Ling Ren; Xinluan Wang; Ke Yang; Ling Qin
Journal:  Regen Biomater       Date:  2022-02-24

Review 10.  Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say?

Authors:  Elizabeth M Curtis; Cyrus Cooper; Nicholas C Harvey
Journal:  Aging Clin Exp Res       Date:  2021-02-09       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.